Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion description "[The presence of COX-2 expression in PJS carcinomas and dysplastic hamartomas provides a rationale for chemoprevention with nonsteroidal anti-inflammatory drugs or COX-2 inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion evidence source_evidence_literature NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion SIO_000772 12912958 NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion wasDerivedFrom befree-20150227 NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_assertion wasGeneratedBy ECO_0000203 NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP657508.RAYB79e-VsgS1-RaJlERtRqp2XPgZf8wW7jR3s5Q_IBmw130_provenance.